Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Completed · Phase 3

Conditions studied: Arthritis, Rheumatoid

In brief

The purpose of this open-label study is to evaluate the long-term safety and efficacy of ABP 501 in adults with moderate to severe rheumatoid arthritis (RA).

Key facts

Study ID

NCT02114931

Run by

Amgen

People needed

467

Starts

2014-04-01

Expected to finish

2016-04-01

Last updated by the study team

2017-04-24

Who can join

Age: 18 and older, up to 81. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject was randomized into protocol 20120262 (NCT01970475) and completed the week 26 visit

You may not qualify if…

• Subject experienced a serious adverse event (SAE) or an adverse event (AE) in the 20120262 study that could cause extension treatment to be detrimental
• Subject completed study 20120262 but cannot be dosed within 4 weeks of the week 26 visit of study 20120262
• Current infection requiring the use of oral or intravenous antibiotics
• Other Inclusion/Exclusion criteria may apply

Where it is running

• Research Site — Peoria, Arizona, United States
• Research Site — Scottsdale, Arizona, United States
• Research Site — Covina, California, United States
• Research Site — El Cajon, California, United States
• Research Site — Hemet, California, United States
• Research Site — Palm Desert, California, United States
• Research Site — Van Nuys, California, United States
• Research Site — Whittier, California, United States
• Research Site — Danbury, Connecticut, United States
• Research Site — Miami, Florida, United States
• Research Site — Orlando, Florida, United States
• Research Site — Sarasota, Florida, United States
• Research Site — Sandy Springs, Georgia, United States
• Research Site — Lexington, Kentucky, United States
• Research Site — Hagerstown, Maryland, United States
• Research Site — Wheaton, Maryland, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Omaha, Nebraska, United States
• Research Site — Brooklyn, New York, United States
• Research Site — Mineola, New York, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Bethlehem, Pennsylvania, United States
• Research Site — Duncansville, Pennsylvania, United States
• Research Site — Charleston, South Carolina, United States
• Research Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.